CRVO
Income statement / Annual
Last year (2023), CervoMed Inc.'s total revenue was $7.14 M,
and the percentage change from the previous year is not available.
In 2023, CervoMed Inc.'s net income was -$2.17 M.
See CervoMed Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$7.14 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$8.44 M |
$1.34 M |
$93,416.00 |
$103,168.00 |
$97,915.00 |
$110,371.00 |
$67,981.00 |
$25,342.00 |
$8,268.00 |
$566,262.00 |
| Gross Profit |
-$1.29 M |
-$1.34 M |
-$93,416.00 |
-$103,168.00 |
-$97,915.00 |
-$110,371.00 |
-$67,981.00 |
-$25,342.00 |
-$8,268.00 |
-$566,262.00 |
| Gross Profit Ratio |
-0.18 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$8.44 M
|
$1.34 M
|
$8.50 M
|
$9.43 M
|
$6.62 M
|
$5.75 M
|
$5.09 M
|
$6.25 M
|
$3.88 M
|
$2.86 M
|
| General & Administrative
Expenses |
$6.52 M
|
$2.14 M
|
$7.45 M
|
$6.44 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$6.52 M
|
$2.14 M
|
$7.45 M
|
$6.44 M
|
$4.83 M
|
$6.17 M
|
$6.19 M
|
$8.59 M
|
$2.52 M
|
$3.91 M
|
| Other Expenses |
$0.00 |
-$2.39 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$14.96 M |
$3.48 M |
$15.94 M |
$15.87 M |
$11.45 M |
$11.92 M |
$11.28 M |
$14.85 M |
$6.40 M |
$6.77 M |
| Cost And Expenses |
$14.96 M |
$3.48 M |
$16.04 M |
$15.97 M |
$11.55 M |
$12.03 M |
$11.35 M |
$14.87 M |
$6.41 M |
$7.34 M |
| Interest Income |
$219,430.00 |
$62,226.00 |
$137,487.00 |
$114,257.00 |
$0.00 |
$151,647.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$0.00 |
$587.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$2.92 M |
$29,686.00 |
$313,117.00 |
$273,503.00 |
| Depreciation &
Amortization |
$5.64 M
|
$3.48 M
|
$93,416.00
|
$103,168.00
|
$97,915.00
|
$110,371.00
|
$67,981.00
|
$25,342.00
|
$8,268.00
|
$566,262.00
|
| EBITDA |
-$2.17 M
|
$0.00
|
-$24.45 M
|
-$15.76 M
|
-$11.37 M
|
-$18.70 M
|
$566,010.00
|
-$18.35 M
|
-$6.40 M
|
-$16.33 M
|
| EBITDA Ratio |
-0.3 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
-1.09
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$5.64 M
|
-$2.33 M
|
-$8.50 M
|
$114,253.00
|
$85,302.00
|
-$6.78 M
|
$8.93 M
|
-$3.53 M
|
-$313,117.00
|
-$9.83 M
|
| Income Before Tax |
-$2.17 M |
-$5.80 M |
-$24.54 M |
-$15.86 M |
-$11.47 M |
-$18.81 M |
-$2.42 M |
-$18.40 M |
-$6.72 M |
-$17.17 M |
| Income Before Tax Ratio
|
-0.3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00 |
-$3.48 M |
-$443,893.00 |
-$1.68 M |
$332,885.00 |
-$437,289.00 |
-$1.06 M |
-$364,796.00 |
$0.00 |
-$2.82 M |
| Net Income |
-$2.17 M |
-$5.80 M |
-$24.10 M |
-$14.19 M |
-$11.80 M |
-$18.37 M |
-$1.36 M |
-$18.04 M |
-$6.72 M |
-$14.35 M |
| Net Income Ratio |
-0.3 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| EPS |
-0.82 |
-11.2 |
-18.51 |
-19.76 |
-131.95 |
-424.93 |
-123.33 |
-1982.96 |
-28852.23 |
-11291.97 |
| EPS Diluted |
-0.82 |
-11.2 |
-18.51 |
-19.76 |
-131.95 |
-424.93 |
-120.35 |
-1982.96 |
-28852.23 |
-11291.97 |
| Weighted Average Shares
Out |
$2.66 M
|
$518,139.00
|
$1.30 M
|
$717,759.00
|
$89,420.00
|
$43,230.00
|
$11,064.00
|
$9,095.81
|
$232.88
|
$1,271.06
|
| Weighted Average Shares
Out Diluted |
$2.66 M
|
$518,139.00
|
$1.30 M
|
$717,759.00
|
$89,420.00
|
$43,230.00
|
$11,338.00
|
$9,095.81
|
$232.88
|
$1,271.06
|
| Link |
|
|
|
|
|
|
|
|
|
|
